306 related articles for article (PubMed ID: 33734316)
1. A review and roadmap of the skin, lung and gut microbiota in systemic sclerosis.
Teaw S; Hinchcliff M; Cheng M
Rheumatology (Oxford); 2021 Dec; 60(12):5498-5508. PubMed ID: 33734316
[TBL] [Abstract][Full Text] [Related]
2. Update on the Gastrointestinal Microbiome in Systemic Sclerosis.
Bellocchi C; Volkmann ER
Curr Rheumatol Rep; 2018 Jun; 20(8):49. PubMed ID: 29943234
[TBL] [Abstract][Full Text] [Related]
3. Gut microbiota profile in systemic sclerosis patients with and without clinical evidence of gastrointestinal involvement.
Patrone V; Puglisi E; Cardinali M; Schnitzler TS; Svegliati S; Festa A; Gabrielli A; Morelli L
Sci Rep; 2017 Nov; 7(1):14874. PubMed ID: 29093509
[TBL] [Abstract][Full Text] [Related]
4. The Microbiome in Systemic Sclerosis: Pathophysiology and Therapeutic Potential.
Kim S; Park HJ; Lee SI
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555792
[TBL] [Abstract][Full Text] [Related]
5. Intestinal microbiome in scleroderma: recent progress.
Volkmann ER
Curr Opin Rheumatol; 2017 Nov; 29(6):553-560. PubMed ID: 28719392
[TBL] [Abstract][Full Text] [Related]
6. Congruent microbiome signatures in fibrosis-prone autoimmune diseases: IgG4-related disease and systemic sclerosis.
Plichta DR; Somani J; Pichaud M; Wallace ZS; Fernandes AD; Perugino CA; Lähdesmäki H; Stone JH; Vlamakis H; Chung DC; Khanna D; Pillai S; Xavier RJ
Genome Med; 2021 Feb; 13(1):35. PubMed ID: 33648559
[TBL] [Abstract][Full Text] [Related]
7. Emerging pathogenic links between microbiota and the gut-lung axis.
Budden KF; Gellatly SL; Wood DL; Cooper MA; Morrison M; Hugenholtz P; Hansbro PM
Nat Rev Microbiol; 2017 Jan; 15(1):55-63. PubMed ID: 27694885
[TBL] [Abstract][Full Text] [Related]
8. Intestinal dysbiosis is common in systemic sclerosis and associated with gastrointestinal and extraintestinal features of disease.
Andréasson K; Alrawi Z; Persson A; Jönsson G; Marsal J
Arthritis Res Ther; 2016 Nov; 18(1):278. PubMed ID: 27894337
[TBL] [Abstract][Full Text] [Related]
9. Does "all disease begin in the gut"? The gut-organ cross talk in the microbiome.
Chaudhary PP; Kaur M; Myles IA
Appl Microbiol Biotechnol; 2024 May; 108(1):339. PubMed ID: 38771520
[TBL] [Abstract][Full Text] [Related]
10. Effect of probiotics on gastrointestinal symptoms and immune parameters in systemic sclerosis: a randomized placebo-controlled trial.
Marighela TF; Arismendi MI; Marvulle V; Brunialti MKC; Salomão R; Kayser C
Rheumatology (Oxford); 2019 Nov; 58(11):1985-1990. PubMed ID: 31056685
[TBL] [Abstract][Full Text] [Related]
11. Microbiome dysbiosis is associated with disease duration and increased inflammatory gene expression in systemic sclerosis skin.
Johnson ME; Franks JM; Cai G; Mehta BK; Wood TA; Archambault K; Pioli PA; Simms RW; Orzechowski N; Arron S; Whitfield ML
Arthritis Res Ther; 2019 Feb; 21(1):49. PubMed ID: 30728065
[TBL] [Abstract][Full Text] [Related]
12. Cause or effect? Interpreting emerging evidence for dysbiosis in systemic sclerosis.
Denton CP; Murray C
Arthritis Res Ther; 2019 Mar; 21(1):81. PubMed ID: 30917857
[TBL] [Abstract][Full Text] [Related]
13. Alteration of Lung and Gut Microbiota in IL-13-Transgenic Mice Simulating Chronic Asthma.
Sohn KH; Baek MG; Choi SM; Bae B; Kim RY; Kim YC; Kim HY; Yi H; Kang HR
J Microbiol Biotechnol; 2020 Dec; 30(12):1819-1826. PubMed ID: 33046682
[TBL] [Abstract][Full Text] [Related]
14. The efficacy and safety of fecal microbiota transplantation in the treatment of systemic sclerosis: A protocol for systematic review and meta analysis.
Zhang S; Lv J; Ren X; Hao X; Zhou P; Wang Y
Medicine (Baltimore); 2020 Jul; 99(28):e21267. PubMed ID: 32664182
[TBL] [Abstract][Full Text] [Related]
15. The microbiome and systemic sclerosis: A review of current evidence.
Tan TC; Noviani M; Leung YY; Low AHL
Best Pract Res Clin Rheumatol; 2021 Sep; 35(3):101687. PubMed ID: 33849778
[TBL] [Abstract][Full Text] [Related]
16. The differential crosstalk of the skin-gut microbiome axis as a new emerging actor in systemic sclerosis.
Russo E; Bellando-Randone S; Carboni D; Fioretto BS; Romano E; Baldi S; El Aoufy K; Ramazzotti M; Rosa I; Lepri G; Di Gloria L; Pallecchi M; Bruni C; Melchiorre D; Guiducci S; Manetti M; Bartolucci GL; Matucci-Cerinic M; Amedei A
Rheumatology (Oxford); 2024 Jan; 63(1):226-234. PubMed ID: 37154625
[TBL] [Abstract][Full Text] [Related]
17. Dynamic changes of gut and lung microorganisms during chronic obstructive pulmonary disease exacerbations.
Sun Z; Zhu QL; Shen Y; Yan T; Zhou X
Kaohsiung J Med Sci; 2020 Feb; 36(2):107-113. PubMed ID: 31782610
[TBL] [Abstract][Full Text] [Related]
18. Gastrointestinal tract involvement in systemic sclerosis: The roles of diet and the microbiome.
Nguyen AD; Andréasson K; McMahan ZH; Bukiri H; Howlett N; Lagishetty V; Lee SM; Jacobs JP; Volkmann ER
Semin Arthritis Rheum; 2023 Jun; 60():152185. PubMed ID: 36870237
[TBL] [Abstract][Full Text] [Related]
19. Gut microbes contribute to variation in solid organ transplant outcomes in mice.
McIntosh CM; Chen L; Shaiber A; Eren AM; Alegre ML
Microbiome; 2018 May; 6(1):96. PubMed ID: 29793539
[TBL] [Abstract][Full Text] [Related]
20. Gut-lung axis: The microbial contributions and clinical implications.
He Y; Wen Q; Yao F; Xu D; Huang Y; Wang J
Crit Rev Microbiol; 2017 Feb; 43(1):81-95. PubMed ID: 27781554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
